Latent cytomegalovirus infection exacerbates experimental colitis

American Journal of Pathology

Volumn 175, Issue 5, 2009, Pages 2034-2042

  Onyeagocha, Chukwuma ^a   Hossain, Mohammad S ^a   Kumar, Amrita ^a   Jones, Rheinallt M ^a   Roback, John ^a   Gewirtz, Andrew T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DEXTRAN SULFATE; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; IMMUNE RESPONSE; INTESTINE FLORA; LATENT PERIOD; MALAISE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD; WEIGHT REDUCTION; WILD TYPE;

EID: 73649137855     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090471     Document Type: Article

References (30)

1. Strober W, Fuss I, Mannon P: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521
2. Irving PM, Gibson PR: Infections and IBD. Nat Clin Pract Gastroenterol Hepatol 2008, 5:18-27
3. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd DS, Woxenius S, Busch MP: Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion 2001, 41:1249-1257
4. Mosca F, Pugni L: Cytomegalovirus infection: the state of the art. J Chemother 2007, 19(Suppl 2):46-48
5. Egli A, Binggeli S, Bodaghi S, Dumoulin A, Funk GA, Khanna N, Leuenberger D, Gosert R, Hirsch HH: Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 2007, 22(Suppl 8):viii72-viii82
6. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M: Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008, 300:413-422
7. Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A: Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:879-884
8. Criscuoli V, Rizzuto MR, Cottone M: Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol 2006, 12:4813-4818
9. Roback JD, Hossain MS, Lezhava L, Gorechlad JW, Alexander SA, Jaye DL, Mittelstaedt S, Talib S, Hearst JE, Hillyer CD, Waller EK: Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation. J Immunol 2003, 171:6023-6031
10. Gewirtz AT, Simon PO Jr, Schmitt CK, Taylor LJ, Hagedorn CH, O'Brien AD, Neish AS, Madara JL: Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest 2001, 107:99-109
11. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E: Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005, 115:695-702
12. Vijay-Kumar M, Wu H, Aitken J, Kolachala VL, Neish AS, Sitaraman SV, Gewirtz AT: Activation of Toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm Bowel Dis 2007, 13:856-864
13. Vijay-Kumar M, Sanders CJ, Taylor RT, Kumar A, Aitken JD, Sitaraman SV, Neish AS, Uematsu S, Akira S, Williams IR, Gewirtz AT: Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest 2007, 117:3909-3921
14. Sanders CJ, Yu Y, Moore DA 3rd, Williams IR, Gewirtz AT: Humoral immune response to flagellin requires T cells and activation of innate immunity. J Immunol 2006, 177:2810-2818
15. Sitaraman SV, Klapproth JM, Moore DA 3rd, Landers C, Targan S, Williams IR, Gewirtz AT: Elevated flagellin-specific immunoglobulins in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2005, 288:G403-G406
16. Kern ER: Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antiviral Res 2006, 71:164-171
17. Kühn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274
18. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A: Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12-and gamma-interferon- dependent mechanism. Infect Immun 1998, 66:5157-5166
19. Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S, Lynch RG: Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology 2002, 123:1527-1542
20. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J Immunol 1996, 157:798-805
21. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, Virgin HW 4th: Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447:326-329
22. Hollander D: Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep 1999, 1:410-416
23. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR: Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 2009, 136:551-563
24. Ziegler TR, Luo M, Estivariz CF, Moore DA 3rd, Sitaraman SV, Hao L, Bazargan N, Klapproth JM, Tian J, Galloway JR, Leader LM, Jones DP, Gewirtz AT: Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am J Physiol Regul Integr Comp Physiol 2008, 294:R402-R410
25. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004, 113:1296-1306
26. Orvar K, Murray J, Carmen G, Conklin J: Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993, 38:2307-2310
27. Pfau P, Kochman ML, Furth EE, Lichtenstein GR: Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol 2001, 96:895-899
28. Pollock JL, Virgin HW 4th: Latency, without persistence, of murine cytomegalovirus in the spleen and kidney. J Virol 1995, 69:1762-1768
29. Brenchley JM, Douek DC: The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3:356-361
30. Kim TW, Seo JN, Suh YH, Park HJ, Kim JH, Kim JY, Oh KI: Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis. World J Gastroenterol 2006, 12:302-305